Jana Nolte

Ms. Jana Nolte


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
JNJana Nolte
Jana Nolte
MKMarius Kirmse
Marius Kirmse
MMMarkus De Marées
Markus De Marées
PPPetra Platen
Petra Platen
Background/Objectives: Low energy availability (LEA) can cause impaired reproductive function, bone health issues, and suppressed immune function, and may result in decreased performance and overall health status. The purpose of this study was to investigate adaptions of body composition, blood status, resting metabolic rate, and endurance performance to gain more comprehensive insights into the symptoms of LEA and the adaptive effects in the athlete population (active women (n = 11) and men (n = 11)). Methods: Three treatments were defined as 45 (EA45, control), 30 (EA30), and 10 (EA10) kcal/kg FFM/day and randomly assigned. Pre- and post-intervention measurements were performed through blood sampling, bioelectrical impedance analysis, resting metabolic rate measurement, the oral glucose tolerance test (OGTT), and the incremental endurance test to exhaustion. Results: There was a significant reduction in body weight and fat mass in EA10 compared to EA45 (p ≤ 0.05). Blood serum levels were altered in triglyceride, uric acid, and creatinine concentrations in EA10 compared to EA45 (p ≤ 0.05). Furthermore, blood glucose was still accumulated after 120 min during OGTT in EA10 compared to EA45 (p ≤ 0.05). The respiratory exchange ratio was reduced during submaximal stages of the incremental treadmill test to exhaustion without influencing performance output after treatment EA10 (p ≤ 0.05). However, the resting metabolic rate did not change (p > 0.05). Conclusions: In conclusion, this short-term study indicates that energy restriction can lead to several metabolic-related adaptations, which suggests that the availability and regulation of glucose and fats are significantly influenced after only five days of LEA in physically active women and men. Future research should focus on longer exposures of LEA and sex-specific comparisons (including the menstrual cycle) on LEA symptoms.

16 January 2026 in Frontiers in Sports and Active Living
Verified
Journal Article
Open access
PDF file
JNJana Nolte
Jana Nolte
MPMalina Pilz
Malina Pilz
KLKirsten Legerlotz
Kirsten Legerlotz
PPPetra Platen
Petra Platen
Introduction: Accurate detection of ovulation is essential for menstrual cycle-based training periodization for female athletes. Although body temperature tracking is a non-invasive method for this purpose, its reliability can vary depending on the measurement site and timing. This study aimed to compare the utility of different body temperature measurement methods and measurement times for ovulation detection. Methods: Seventeen recreationally active women tracked one menstrual cycle (October 2023 to February 2024) using continuous intravaginal core body temperature measurement as the reference method. Additional temperature measurements (sublingual, rectal and external ear) were taken at two points in time: 6 a.m. and upon waking. Ovulation was additionally confirmed using luteinizing hormone urinary tests. The post-ovulatory temperature increase was analyzed using both the validated Vollman method and the practical “three over six” rule for the four different methods and two different time points. Agreement of the measurement methods and times was assessed via Bland–Altman plots and concordance correlation coefficients. Results: The continuous intravaginal temperature sensor consistently identified ovulation with acceptable accuracy, detecting all ovulations and showing the largest temperature rise from follicular to luteal phase (0.31 ± 0.18 °C). Sublingual 6 a.m. measurements showed smaller temperature increases (0.17 ± 0.24 °C) and moderate agreement with the reference, whereas rectal (0.12 ± 0.21 °C) and external ear temperatures (0.22 ± 0.38 °C) exhibited higher variability and limited reliability. One cycle was confirmed as anovulatory and correctly identified by the intravaginal sensor. Discussion: The most reliable method for detecting ovulation in physically active women is continuous intravaginal temperature measurement. If this method is not available, a trained sublingual temperature measurement at a fixed time can be an acceptable, cost-effective alternative. All methods have their limitations.

13 March 2026 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
JNJana Nolte
Jana Nolte
SVSven C. Voss
Sven C. Voss
AKAnnekathrin Martina Keiler
Annekathrin Martina Keiler
EBEmily Büthe
Emily Büthe
KLKirsten Legerlotz
Kirsten Legerlotz
PPPetra Platen
Petra Platen
Background: Understanding variations in the androgen profile is crucial for interpreting hormone data and developing cycle-based training strategies tailored to individual athlete needs. Therefore, this study investigates the androgen concentrations of elite female track and field athletes across various hormonal conditions, including natural eumenorrheic cycles, cycles under hormonal contraception, and cycles with menstrual disturbances. Methods: Using a prospective, longitudinal observational cohort design, 22 athletes (15 naturally cycling, 7 using hormonal contraception) were monitored for up to three consecutive cycles. The study utilised daily or near-daily urine sampling to analyse urinary steroid hormones (including testosterone and its metabolites) via gas chromatography-coupled mass spectrometry (GC-MS/MS). Results: Results demonstrated that in athletes with ovulatory menstrual cycles, urinary androgen concentrations, particularly testosterone, varied significantly by phase, peaking around the late follicular phase (lateFP: 7.35 ± 6.25 ng/mL). In contrast, athletes using combined oral contraceptives exhibited significantly suppressed androgen concentrations throughout the cycle compared to the natural cycle group, with mean urinary testosterone levels being notably lower (2.55 ± 2.91 ng/mL vs. 5.45 ± 4.31 ng/mL; p <0.001). These pill users also showed elevated concentrations of the inactive 5β-reductase metabolites (5β-androstanedione and 5β-androstanediol). Cycles with menstrual disturbances, such as luteal phase deficiency, also displayed altered and often lower concentrations of all urinary androgens. Conclusion: These findings highlight the significant influence of both endogenous menstrual cycle dynamics and exogenous hormone interventions on androgen availability, underscoring the necessity of considering the individual hormone status for performance optimization and athlete health management.


29 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
JNJana Nolte
Jana Nolte
ITIsabell Thal
Isabell Thal
EBEmily Büthe
Emily Büthe
SWSusanne Weber
Susanne Weber
PPPetra Platen
Petra Platen
KLKirsten Legerlotz
Kirsten Legerlotz
Background: The number of elite female athletes navigating pregnancy continues to rise, yet the intersection of high-performance sport and motherhood remains understudied. This scoping review summarizes the literature on training, performance, physical health, and psychological aspects before, during, and after pregnancy in elite athletes (tiers 3–5). The aim is to identify knowledge gaps and to inform future research. Methods: This review was conducted in accordance with the PRISMA-ScR guidelines and was registered with PROSPERO (CRD420250651470). At 8 th of January 2025, a systematic search of 10 databases (e.g., PubMed, Scopus, and PsycINFO) was conducted. Studies were eligible for inclusion if they involved elite female athletes during the pre-pregnancy, pregnancy, or postpartum phases. Data extraction included information on study design, athlete classification, training, health, performance, and psychological outcomes. Results: Of the 5,236 records examined, 102 studies met the inclusion criteria and 47 original research articles underwent detailed data extraction. Elite athletes often plan their pregnancies very carefully. Although high-performance training combined with a healthy diet does not necessarily impair fertility, some athletes reduce their training to support their fertility. Furthermore, there is no evidence to suggest that high training loads have a negative impact on the course of pregnancy. Evidence shows that elite athletes typically continue to train throughout pregnancy, adjusting the load, and resume training early after childbirth. Although highly individualized, performance recovery is feasible. Moderate-intensity exercise appears to be safe, but thresholds above 90% of maximum heart rate may impact fetal responses. Psychological stress, identity conflicts, and a lack of tailored guidelines are common challenges. Most birth outcomes match or exceed those of the general population. Conclusions: Despite the emergence of new evidence, there are still significant gaps in the research regarding individualized training protocols, postpartum return to sport strategies, and mental health interventions for elite athletes peri- and post-pregnancy. The current literature favors endurance sports and Western populations, highlighting the need for more diverse, prospective, and interdisciplinary research. Registration: The protocol for this review was registered in the PROSPERO database (CRD420250651470).

9 March 2026 in Sports Medicine - Open
Verified
Journal Article
Open access
PDF file
JNJana Nolte
Jana Nolte
ITIsabell Thal
Isabell Thal
EBEmily Büthe
Emily Büthe
SWSusanne Weber
Susanne Weber
PPPetra Platen
Petra Platen
KLKirsten Legerlotz
Kirsten Legerlotz
Background: The number of elite female athletes navigating pregnancy continues to rise, yet the intersection of high-performance sport and motherhood remains understudied. This scoping review summarizes the literature on training, performance, physical health, and psychological aspects before, during, and after pregnancy in elite and sub-elite athletes (tiers 3–5). The aim is to identify knowledge gaps and to inform future research. Methods: This review was conducted in accordance with the PRISMA-ScR guidelines and was registered with PROSPERO (CRD420250651470). At 8th of January 2025, a systematic search of 10 databases (e.g., PubMed, Scopus, and PsycINFO) was conducted. Studies were eligible for inclusion if they involved highly (or more) trained female athletes during the pre-pregnancy, pregnancy, or postpartum phases. Data extraction included information on study design, athlete classification, training, health, performance, and psychological outcomes. Results: Of the 5236 records examined, 101 studies met the inclusion criteria and 46 original research articles underwent detailed data extraction. Elite and sub-elite athletes often plan their pregnancies very carefully. The available evidence does not clearly demonstrate negative effects of high training loads on pregnancy outcomes. However, the limited, often outdated, and predominantly endurance-focused data do not allow firm conclusions. Evidence shows that elite and sub-elite athletes typically continue to train throughout pregnancy, adjusting the load, and resume training early after childbirth. Although highly individualized, performance recovery is feasible. Moderate-intensity exercise appears to be safe, but thresholds above 90% of maximum heart rate may impact fetal responses. Psychological stress, identity conflicts, and a lack of tailored guidelines are common challenges. Most birth outcomes match or exceed those of the general population. Conclusions: While no consistent evidence of adverse pregnancy outcomes from high training loads has been reported, the existing studies are too limited and heterogeneous to allow firm conclusions. These gaps, along with an evidence base largely derived from endurance-focused sports and Western populations, highlight the ongoing need for more diverse, contemporary, and sport-specific research on training, return-to-sport, and mental health in pregnant elite athletes. Registration The protocol for this review was registered in the PROSPERO database (CRD420250651470).